Movement Disorders

Progressive symptoms make participant engagement challenging in movement disorder studies. Our patient-centric technology simplifies participation and reduces burden, resulting in higher retention rates.

Inconsistent movement symptom assessment compromises study outcomes. Our standardized electronic data capture includes built-in quality controls to ensure accurate measurement across all sites.

Our technology captures real-world symptom data while reducing travel burden for patients with mobility limitations, allowing you to maintain data integrity without requiring frequent clinic visits.

Our enhanced clinician ratings platform guides investigative staff through proper assessment technique with automated scoring and built-in edit checks that significantly reduce errors. When paired with PureSignal Analytics, we proactively monitor COA data in real-time, creating opportunities to mitigate quality risks before they impact your signal detection capability.

Movement disorder endpoints rely on specialized scales, but scoring inconsistencies can compromise data quality. Our Rater Training program standardizes assessment techniques and reduces variability across sites.

Our agile technologies support protocol adjustments and enable data-driven decisions throughout your study, helping you respond to emerging insights without compromising quality.

Extensive network of movement disorder experts allow for adjudication, independent scoring, and local language site remediation among other things.

For movement disorder studies involving pediatric populations, Signant has unparalleled experience in helping design and conduct trials that sensitively and accurately capture needed assessments.